Although a vast majority of radiologists qualify under the federal government’s meaningful use incentive program for electronic health records, many have lingering concerns about the program, according to a new KLAS and RSNA survey.
Although a vast majority of radiologists qualify under the federal government’s meaningful use incentive program for electronic health records, many have lingering concerns about the program.
In a new survey of 216 radiologists, 40 percent said they had concerns about the lack of clarity of the guidelines or decreased efficiency as a result of adopting the current guidelines. The survey, Radiologists' Take on Meaningful Use: a KLAS-RSNA Report, was conducted by KLAS and RSNA and includes feedback from private practice, hospital-based, and academic radiologists.
Sixty percent of those surveyed said they either plan to or are considering qualifying for meaningful use, but only 6 percent reported that they considered themselves educated on the program.
"These numbers should be a wakeup call for the radiology industry," said Emily Crane, KLAS research director and author of the report. "Getting educated and involved with meaningful use can't wait."
Some radiologists said they were concerned the guidelines don’t take radiology into consideration, and said that clinical decision support would be a beneficial criteria and an important means for ensuring the correct test is ordered. Radiologists also felt that dose tracking and patient engagement were among the least beneficial criteria in the program. In follow-up interviews, radiologists said although patients have a right to their records, there was no apparent medical benefit or necessity for them to have electronic access to their images and reports, according to KLAS.
“We hope that this feedback from radiologists can serve as a guide for the Office of the National Coordinator for HIT and those in Washington who are currently addressing Stage 2 and Stage 3 guidelines. Radiologists would like guidelines that are more appropriate for their practice of radiology," said Crane.
KLAS also asked questions about vendor preparedness to help providers achieve meaningful use. On average, 25 percent of respondents felt their RIS and PACS vendor was not prepared to help them meet the requirements.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.